10 Most-Read Stories of 2016

Panelists at SupplySide Global 2026 discussed protein's limits, shifting supplement formats, clean-label expectations, and plainer ingredient communication.

Ixoreal Biomed highlights an exploratory placebo-controlled study of SRI-81 Shatavari, alone and combined with KSM-66 Ashwagandha, published in the International Journal of Women’s Health.

Clinical research moves beyond compliance, focusing on smarter trial design, risk-based quality, and “evidence engineering” to deliver decisive, decision-ready results.

The four-formula line is Olly’s second retailer-exclusive launch this year, following the launch of a probiotic range in April.

The company’s new division offers bovine, porcine, ovine, poultry glandulars for supplements, pet food, and animal feed, highlighting a full QA document package.

Why responsible innovation means asking whether yesterday's formulations still reflect today's best science—not just launching the next new ingredient.

A new Walmart-exclusive supplement from Lemme joins a fast-growing, category of products marketed around the body's natural GLP-1 production.

BENEO's Denisse Colindres discusses how the fibermaxxing trend is evolving beyond "more fiber" to fiber diversity and layering, and what that shift means for formulation, claims, and category opportunity.